Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation

被引：0
|
作者：
Chunxia Qiao
Meiyun Hu
Leiming Guo
Ming Lv
Zhou Lin
Jing Geng
Xiaoling Lang
Xinying Li
Yan Li
Yuanfang Ma
Jiannan Feng
Beifen Shen
机构：
[1] Institute of Basic Medical Sciences,Department of Immunology
[2] Henan University,Laboratory of Cellular and Molecular Immunology, Institute of Immunology
来源：
BMC Immunology | / 13卷
关键词：
TRAIL; Death receptor 5; Monoclonal antibody; Apoptosis; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Extensive regions of the FADD death domain are required for binding to the TRAIL receptor DR5
    Thomas, LR
    Bender, LM
    Morgan, MJ
    Thorburn, A
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (01): : 160 - 162
  • [12] The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis
    Silvia Colucci
    Giacomina Brunetti
    Francesco Paolo Cantatore
    Angela Oranger
    Giorgio Mori
    Paolo Pignataro
    Roberto Tamma
    Felice Roberto Grassi
    Alberta Zallone
    Maria Grano
    Apoptosis, 2007, 12
  • [13] The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis
    Colucci, Silvia
    Brunetti, Giacomina
    Cantatore, Francesco Paolo
    Oranger, Angela
    Mori, Giorgio
    Pignataro, Paolo
    Tamma, Roberto
    Grassi, Felice Roberto
    Zallone, Alberta
    Grano, Maria
    APOPTOSIS, 2007, 12 (09) : 1623 - 1632
  • [14] Molecular imaging of Death Receptor 5 (DR5) occupancy in-vivo by humanized monoclonal antibody CS-1008
    Scott, A. M.
    Lee, F. T.
    Cartwright, G. C.
    O'Keefe, G. J.
    Beckman, R. A.
    Fujiwara, K.
    von Roemeling, R.
    EJC SUPPLEMENTS, 2010, 8 (07): : 78 - 78
  • [15] MOLECULAR IMAGING OF DEATH RECEPTOR 5 (DR5) OCCUPANCY IN-VIVO BY HUMANIZED MONOCLONAL ANTIBODY CS-1008
    Scott, A.
    Lee, F.
    Cartwright, G.
    O'Keefe, G.
    Beckman, R.
    Fujiwara, K.
    von Romeling, R.
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 18 - 18
  • [16] Targeted depletion of macrophages using an anti-human DR5 antibody prevented arthritis in a novel human/mouse chimeric DR5 Tg mouse
    Li, Jun
    Yang, Ping-Ar
    Wu, Qi
    Hsu, Hui-Chen
    Mountz, John
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [17] Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
    Ichikawa, K
    Liu, WM
    Zhao, LM
    Wang, Z
    Liu, D
    Ohtsuka, T
    Zhang, HG
    Mountz, JD
    Koopman, WJ
    Kimberly, RP
    Zhou, T
    NATURE MEDICINE, 2001, 7 (08) : 954 - 960
  • [18] Tumoricidal activity in the absence of hepatocyte cytotoxicity of a novel anti-human DR5 monoclonal antibody
    Ichikawa, K
    Liu, WM
    Wang, Z
    Liu, D
    Zhao, LM
    Zhang, HG
    Mountz, JD
    Koopman, WJ
    Kimberley, RP
    Zhou, T
    FASEB JOURNAL, 2001, 15 (05): : A1198 - A1198
  • [19] Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
    Kimihisa Ichikawa
    Weimin Liu
    Limin Zhao
    Zheng Wang
    Di Liu
    Toshiaki Ohtsuka
    Huangge Zhang
    John D. Mountz
    William J. Koopman
    Robert P. Kimberly
    Tong Zhou
    Nature Medicine, 2001, 7 : 954 - 960
  • [20] Efficacy of anti-death receptor 5 (DR5) antibody (TRA-8) against primary human ovarian carcinoma using a novel ex vivo tissue slice model
    Estes, Jacob M.
    Oliver, Patsy G.
    Straughn, J. Michael, Jr.
    Zhou, Tong
    Wang, Wenquan
    Grizzle, William E.
    Alvarez, Ronald D.
    Stockard, Cecil R.
    LoBuglio, Albert F.
    Buchsbaum, Donald J.
    GYNECOLOGIC ONCOLOGY, 2007, 105 (02) : 291 - 298
12345